KR100368563B1 - 안티-d면역글로불린g농축액및이를함유하는약제학적제제의제조방법 - Google Patents

안티-d면역글로불린g농축액및이를함유하는약제학적제제의제조방법 Download PDF

Info

Publication number
KR100368563B1
KR100368563B1 KR1019950703644A KR19950703644A KR100368563B1 KR 100368563 B1 KR100368563 B1 KR 100368563B1 KR 1019950703644 A KR1019950703644 A KR 1019950703644A KR 19950703644 A KR19950703644 A KR 19950703644A KR 100368563 B1 KR100368563 B1 KR 100368563B1
Authority
KR
South Korea
Prior art keywords
igg
preparation
immunoglobulin
plasma
adsorbent
Prior art date
Application number
KR1019950703644A
Other languages
English (en)
Korean (ko)
Other versions
KR960701098A (ko
Inventor
게르하트호들러
독토르페터러치
독토르마르틴스튜키
Original Assignee
체트엘베 바이오플라스마 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8215103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR100368563(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 체트엘베 바이오플라스마 아게 filed Critical 체트엘베 바이오플라스마 아게
Publication of KR960701098A publication Critical patent/KR960701098A/ko
Application granted granted Critical
Publication of KR100368563B1 publication Critical patent/KR100368563B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1019950703644A 1993-12-27 1994-12-22 안티-d면역글로불린g농축액및이를함유하는약제학적제제의제조방법 KR100368563B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93810912A EP0659767B2 (de) 1993-12-27 1993-12-27 Verfahren zur Herstellung eines Konzentrates von Anti-D-Immunoglobulin G und pharmazeutische Zusammensetzung, die dieses enthält
AT93810912.1 1993-12-27

Publications (2)

Publication Number Publication Date
KR960701098A KR960701098A (ko) 1996-02-24
KR100368563B1 true KR100368563B1 (ko) 2003-04-03

Family

ID=8215103

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950703644A KR100368563B1 (ko) 1993-12-27 1994-12-22 안티-d면역글로불린g농축액및이를함유하는약제학적제제의제조방법

Country Status (20)

Country Link
US (1) US5593675A (ja)
EP (1) EP0659767B2 (ja)
JP (1) JP2926463B2 (ja)
KR (1) KR100368563B1 (ja)
AT (1) ATE175979T1 (ja)
AU (1) AU682243B2 (ja)
CA (1) CA2138921C (ja)
CZ (1) CZ286271B6 (ja)
DE (1) DE59309332D1 (ja)
DK (1) DK0659767T4 (ja)
ES (1) ES2129076T5 (ja)
FI (1) FI112168B (ja)
GR (1) GR3029817T3 (ja)
HU (1) HU216864B (ja)
NO (1) NO315331B1 (ja)
NZ (1) NZ278057A (ja)
PL (1) PL180358B1 (ja)
SI (1) SI9420008B (ja)
TW (1) TW311884B (ja)
WO (1) WO1995018155A1 (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2198913T5 (es) * 1998-05-06 2013-11-18 Genentech, Inc. Purificación de proteínas mediante cromatografía de intercambio iónico
US6281336B1 (en) * 1998-06-09 2001-08-28 Statens Serum Institut Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
DE19923027C2 (de) * 1999-05-19 2002-09-19 Aventis Behring Gmbh Verfahren zur Inaktivierung von Viren
US6475749B1 (en) * 1999-08-11 2002-11-05 The Regents Of The University Of California Rh hybrid antibody
SE0001128D0 (sv) * 2000-03-30 2000-03-30 Amersham Pharm Biotech Ab A method of producing IgG
ES2184594B1 (es) * 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
EP1532983A1 (en) 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulin preparations having increased stability
CA2458750C (en) 2004-02-23 2012-02-07 Bayer Inc. Isoolefin-diolefin production process and apparatus therefor
US20060263357A1 (en) * 2005-05-05 2006-11-23 Tedder Thomas F Anti-CD19 antibody therapy for autoimmune disease
TWI391399B (zh) 2005-05-25 2013-04-01 Hoffmann La Roche 測定溶離多肽之鹽濃度之方法
EA017152B1 (ru) * 2006-08-28 2012-10-30 Арес Трейдинг С.А. СПОСОБ ОЧИСТКИ Fc-СОДЕРЖАЩИХ БЕЛКОВ
BRPI0716139A2 (pt) * 2006-08-28 2013-09-17 Ares Trading Sa processo para purificaÇço de proteÍnas de fusço fc
IT1397061B1 (it) * 2009-12-28 2012-12-28 Kedrion Spa Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale.
WO2011095543A1 (en) 2010-02-04 2011-08-11 Csl Behring Ag Immunoglobulin preparation
EP2361636A1 (en) 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation
RU2467783C2 (ru) * 2010-07-30 2012-11-27 Закрытое акционерное общество "БиоХимМак СТ" Способ хроматографического выделения иммуноглобулина
PT2616090T (pt) * 2010-09-17 2023-10-16 Takeda Pharmaceuticals Co Estabilização de imunoglobulinas através de formulação aquosa com histidina em ph fracamente ácido a neutro
TWI610937B (zh) 2011-08-26 2018-01-11 巴克斯歐塔公司 用於降低血漿來源免疫球蛋白組成物之血栓性栓塞可能性的方法
AU2013203043B2 (en) * 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
EP3118210B1 (en) * 2014-03-11 2019-11-13 Green Cross Holdings Corporation Method for purifying immunoglobulin
WO2015137530A1 (ko) * 2014-03-11 2015-09-17 주식회사 녹십자홀딩스 면역글로불린의 정제방법
EP4349859A1 (en) * 2023-01-27 2024-04-10 CSL Behring AG Method to purify anti-d immunoglobulin g from plasma

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869436A (en) * 1971-06-01 1975-03-04 Statens Bakteriologiska Lab Method for fractionating plasma proteins using peg and ion-exchangers
ATE19735T1 (de) * 1982-02-08 1986-05-15 Schweiz Serum & Impfinst Intravenoes verabreichbares humanes immunglobulin und verfahren zu dessen herstellung.
US4434093A (en) * 1982-07-26 1984-02-28 Ortho Diagnostic Systems Inc. Methods for preparation of HBs Ag free gamma globulins
DE3640513A1 (de) * 1986-11-27 1988-06-09 Biotest Pharma Gmbh Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
US5118796A (en) * 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
US5138034A (en) * 1989-07-12 1992-08-11 The Green Cross Corporation Method of fractionating plasma proteins
US5177194A (en) * 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins

Also Published As

Publication number Publication date
JP2926463B2 (ja) 1999-07-28
NZ278057A (en) 1997-03-24
TW311884B (ja) 1997-08-01
AU1414395A (en) 1995-07-17
JPH07206708A (ja) 1995-08-08
AU682243B2 (en) 1997-09-25
CA2138921A1 (en) 1995-06-28
NO945032L (no) 1995-06-28
EP0659767B1 (de) 1999-01-20
FI946103A (fi) 1995-06-28
PL180358B1 (pl) 2001-01-31
ATE175979T1 (de) 1999-02-15
NO315331B1 (no) 2003-08-18
DK0659767T4 (da) 2003-02-10
DK0659767T3 (da) 1999-09-13
ES2129076T5 (es) 2003-05-16
CZ286271B6 (cs) 2000-03-15
CA2138921C (en) 2004-11-02
EP0659767B2 (de) 2002-11-06
DE59309332D1 (de) 1999-03-04
US5593675A (en) 1997-01-14
PL310435A1 (en) 1995-12-11
HUT73376A (en) 1996-07-29
SI9420008A (en) 1996-02-29
SI9420008B (sl) 1998-06-30
NO945032D0 (no) 1994-12-23
KR960701098A (ko) 1996-02-24
FI946103A0 (fi) 1994-12-27
WO1995018155A1 (en) 1995-07-06
ES2129076T3 (es) 1999-06-01
EP0659767A1 (de) 1995-06-28
HU216864B (hu) 1999-09-28
FI112168B (fi) 2003-11-14
CZ249295A3 (en) 1996-01-17
HU9502514D0 (en) 1995-11-28
GR3029817T3 (en) 1999-06-30

Similar Documents

Publication Publication Date Title
KR100368563B1 (ko) 안티-d면역글로불린g농축액및이를함유하는약제학적제제의제조방법
JP5478519B2 (ja) 静脈投与用免疫グロブリン及び他の免疫グロブリン生成物の製造法
JP4685238B2 (ja) 静脈投与用免疫グロブリン及び他の免疫グロブリン生成物の製造法
CA2941230C (en) Method for purifying immunoglobulin
US9782477B2 (en) Fraction I-IV-1 precipitation of immunoglobins from plasma
EP3305800B1 (en) Preparation method of plasma-derived hepatitis b human immunoglobulin agent
JP2014520829A (ja) 多価免疫グロブリン濃縮物の製造方法
KR100236762B1 (ko) 사람 혈장의 분별 동안에 생성된 분별물로부터 면역글로불린을 회수하는 방법
EP0973549A2 (en) Intravenous immune globulin formulation containing a non-ionic surface active agent with improved pharmacokinetic properties
Yap Humoral Functions of Immunoglobulin: Relationship to Purification Technology of Intravenous Immunoglobulin
MXPA00012230A (en) Process for producing immunoglobulins for intravenous administration and other immunoglobulin products

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee